EGFR gene copy number alterations are not a useful screening tool for predicting EGFR mutation status in lung adenocarcinoma
Prudence A Russell, Yong Yu, Hongdo Do, Timothy D Clay, Melissa M Moore, Gavin M Wright, Matthew Conron, Zoe Wainer, Alexander Dobrovic, Sue-Anne McLachlan
Pathology | ELSEVIER | Published : 2014
Related Projects (1)
Awarded by National Health and Medical Research Council
Funding for this study was provided by St Vincent's Hospital research endowment fund and a concept development grant from the Australasian Lung Cancer Trials Group. TDC was supported by Australian Postgraduate Award from the University of Melbourne. GMW was supported by National Health and Medical Research Council Scholarship GNT 1038699 and University of Melbourne Medical Postgraduate Committee Gordon-Taylor Scholarship. The authors state that there are no conflicts of interest to disclose.